Roxana U. Miranda

687 total citations
14 papers, 471 citations indexed

About

Roxana U. Miranda is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Roxana U. Miranda has authored 14 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Hepatology and 4 papers in Oncology. Recurrent topics in Roxana U. Miranda's work include Liver Disease Diagnosis and Treatment (7 papers), Liver Disease and Transplantation (3 papers) and Microbial Metabolism and Applications (3 papers). Roxana U. Miranda is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver Disease and Transplantation (3 papers) and Microbial Metabolism and Applications (3 papers). Roxana U. Miranda collaborates with scholars based in Mexico, Germany and Spain. Roxana U. Miranda's co-authors include Javier Barrios-González, Luis E. Gómez-Quiroz, Verónica Souza, Leticia Bucio, María Concepción Gutiérrez‐Ruíz, Mayra Domínguez‐Pérez, Natalia Nuño‐Lámbarri, Jens U. Marquardt, Francisco Fierro and Armando Mejía and has published in prestigious journals such as Applied Microbiology and Biotechnology, Journal of Cellular Physiology and Food and Chemical Toxicology.

In The Last Decade

Roxana U. Miranda

14 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roxana U. Miranda Mexico 12 201 168 132 115 60 14 471
Sandrine Martin France 6 269 1.3× 168 1.0× 25 0.2× 56 0.5× 94 1.6× 8 547
Mohammad Akbar Hossain South Korea 10 192 1.0× 126 0.8× 16 0.1× 43 0.4× 24 0.4× 12 417
Anhui Gao China 14 390 1.9× 147 0.9× 26 0.2× 61 0.5× 48 0.8× 30 680
Bing‐Ying Ho Taiwan 12 130 0.6× 85 0.5× 176 1.3× 33 0.3× 38 0.6× 17 443
Titto Augustine United States 12 231 1.1× 56 0.3× 53 0.4× 37 0.3× 21 0.3× 19 496
Cristina Gómez Spain 10 131 0.7× 36 0.2× 34 0.3× 58 0.5× 38 0.6× 12 352
Hongsheng Lin China 13 337 1.7× 117 0.7× 13 0.1× 53 0.5× 75 1.3× 26 697
Yunke Yang China 8 187 0.9× 46 0.3× 15 0.1× 43 0.4× 19 0.3× 17 358
Isabel Moreira da Silva Portugal 9 281 1.4× 27 0.2× 18 0.1× 189 1.6× 45 0.8× 22 602
Jianqiong Yang China 12 178 0.9× 28 0.2× 17 0.1× 58 0.5× 54 0.9× 24 425

Countries citing papers authored by Roxana U. Miranda

Since Specialization
Citations

This map shows the geographic impact of Roxana U. Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxana U. Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxana U. Miranda more than expected).

Fields of papers citing papers by Roxana U. Miranda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxana U. Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxana U. Miranda. The network helps show where Roxana U. Miranda may publish in the future.

Co-authorship network of co-authors of Roxana U. Miranda

This figure shows the co-authorship network connecting the top 25 collaborators of Roxana U. Miranda. A scholar is included among the top collaborators of Roxana U. Miranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxana U. Miranda. Roxana U. Miranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Mata‐Espinosa, Dulce, Verónica Souza, Roxana U. Miranda, et al.. (2019). Hepatocyte growth factor enhances the clearance of a multidrug‐resistant Mycobacterium tuberculosis strain by high doses of conventional chemotherapy, preserving liver function. Journal of Cellular Physiology. 235(2). 1637–1648. 6 indexed citations
2.
Domínguez, Mayrel Palestino, Mario Peláez‐Luna, Verónica Souza, et al.. (2018). Recombinant human hepatocyte growth factor provides protective effects in cerulein‐induced acute pancreatitis in mice. Journal of Cellular Physiology. 233(12). 9354–9364. 18 indexed citations
3.
Domínguez‐Pérez, Mayra, Arturo Simoni‐Nieves, Natalia Nuño‐Lámbarri, et al.. (2018). Cholesterol burden in the liver induces mitochondrial dynamic changes and resistance to apoptosis. Journal of Cellular Physiology. 234(5). 7213–7223. 57 indexed citations
4.
Souza, Verónica, Roxana U. Miranda, Armando Luna‐López, et al.. (2017). Cholesterol overload in the liver aggravates oxidative stress-mediated DNA damage and accelerates hepatocarcinogenesis. Oncotarget. 8(61). 104136–104148. 37 indexed citations
5.
Domínguez‐Pérez, Mayra, Natalia Nuño‐Lámbarri, Denise Clavijo‐Cornejo, et al.. (2016). Hepatocyte Growth Factor Reduces Free Cholesterol‐Mediated Lipotoxicity in Primary Hepatocytes by Countering Oxidative Stress. Oxidative Medicine and Cellular Longevity. 2016(1). 7960386–7960386. 30 indexed citations
6.
Nuño‐Lámbarri, Natalia, Mayra Domínguez‐Pérez, María J. Monte, et al.. (2016). Liver Cholesterol Overload Aggravates Obstructive Cholestasis by Inducing Oxidative Stress and Premature Death in Mice. Oxidative Medicine and Cellular Longevity. 2016(1). 9895176–9895176. 26 indexed citations
7.
López-Reyes, Alberto, Karina Martínez‐Flores, Denise Clavijo‐Cornejo, et al.. (2016). [Cholesterol overload in hepatocytes affects nicotinamide adenine dinucleotide phosphate oxidase (NADPH) activity abrogating hepatocyte growth factor (HGF) induced cellular protection].. PubMed. 151(4). 456–64. 5 indexed citations
8.
Sánchez, Victoria Chagoya de, Mayrel Palestino Domínguez, Verónica Souza, et al.. (2015). Cholesterol Enhances the Toxic Effect of Ethanol and Acetaldehyde in Primary Mouse Hepatocytes. Oxidative Medicine and Cellular Longevity. 2016(1). 9209825–9209825. 20 indexed citations
9.
Murray, Nigel P, et al.. (2015). Diagnostic Yield of Primary Circulating Tumor Cells in Women Suspected of Breast Cancer: the BEST (Breast Early Screening Test) Study. Asian Pacific Journal of Cancer Prevention. 16(5). 1929–1934. 13 indexed citations
10.
Domínguez‐Pérez, Mayra, Leticia Bucio, Verónica Souza, et al.. (2014). Free fatty acids enhance the oxidative damage induced by ethanol metabolism in an in vitro model. Food and Chemical Toxicology. 76. 109–115. 14 indexed citations
11.
Clavijo‐Cornejo, Denise, Mayrel Palestino Domínguez, Mayra Domínguez‐Pérez, et al.. (2014). Acetaldehyde targets superoxide dismutase 2 in liver cancer cells inducing transient enzyme impairment and a rapid transcriptional recovery. Food and Chemical Toxicology. 69. 102–108. 17 indexed citations
12.
Miranda, Roxana U., et al.. (2014). Reactive oxygen species regulate lovastatin biosynthesis in Aspergillus terreus during submerged and solid-state fermentations. Fungal Biology. 118(12). 979–989. 45 indexed citations
13.
Miranda, Roxana U., Luis E. Gómez-Quiroz, Armando Mejía, & Javier Barrios-González. (2012). Oxidative state in idiophase links reactive oxygen species (ROS) and lovastatin biosynthesis: Differences and similarities in submerged- and solid-state fermentations. Fungal Biology. 117(2). 85–93. 33 indexed citations
14.
Barrios-González, Javier & Roxana U. Miranda. (2009). Biotechnological production and applications of statins. Applied Microbiology and Biotechnology. 85(4). 869–883. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026